Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.

J Clin Oncol. 2024 Jan 1;42(1):19-25.

Více informací ZDE 

Risk Modeling for Individualization of the FLAME Focal Boost Approach in External Beam Radiation Therapy for Patients With Localized Prostate Cancer.

Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):66-73.

Více informací ZDE 

Salivary Electrostimulation in the Treatment of Radiation Therapy-Induced Xerostomia (LEONIDAS-2): A Multicenter, Randomized, Double-Masked, Sham-Controlled, Phase 3 Trial.

Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):142-153.

Více informací ZDE 

Hypofractionated, Dose Escalation Radiation Therapy for High-Risk Prostate Cancer: The Safety Analysis of the Prostate Cancer Study-5, a Groupe de Radio-Oncologie Génito-Urinaire de Quebec Led Phase 3 Trial.

Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):52-62.

Více informací ZDE 

Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.

N Engl J Med. 2024 Feb 29;390(9):819-829.

Více informací ZDE 

Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.

J Clin Oncol. 2024 Feb 10;42(5):500-506.

Více informací ZDE 

Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase 2B Trial of Proton Beam Therapy Versus Intensity Modulated Radiation Therapy.

Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):368-377.

Více informací ZDE 

Trimodality Therapy With Iodine-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-Term Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer: Results of a Multicenter, Randomized Phase 3 Trial (TRIP/TRIGU0907).

Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):390-401.

Více informací ZDE 

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial.

JAMA Oncol. 2024 Mar 1;10(3):325-334.

Více informací ZDE 

Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery.

Int J Radiat Oncol Biol Phys. 2024 Mar 15;118(4):1049-1059.

Více informací ZDE 

Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Long-Term Results From the PKUFH Randomized Phase 3 Trial.

Int J Radiat Oncol Biol Phys. 2024 Mar 1;118(3):697-705.

Více informací ZDE